News

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 millions (approx. USD 112 millions).

The round was co-led by the European healthcare focused investment firms Forbion and JEITO Capital. UPMC Enterprises and an additional new investor joined existing investors Sofinnova Partners, Polaris Inc., Gilde Healthcare and The Invus Group to complete the round.

The proceeds of the Series B financing will be used to advance Noema Pharma’s clinical-stage assets. Following the closing of this Series B financing round, Nanna Lüneborg from Forbion and Rachel Mears from Jeito Capital will join the board of directors of Noema Pharma Ltd.

BGPartner advised co-lead investors Forbion and Jeito Capital on all Swiss legal matters and the negotiations of this Series B financing round. The core team consisted of Oliver Gnehm (Partner) and Victoria Marty (Associate) and furthermore comprised Olivier Bula (Partner), Fabiola Weilenmann-Anthamatten (Managing Associate) and Geremia Stüssi (Jurist).

More information can be found here.

The answer to the question "what makes a professional network strong" is multifaceted. However, one thing is clear: a network is only as strong as the relationships among its members. And this is cultivated at LAWorld in the form of regular get-togethers.

The event proved once again that LAWorld is a unique and vibrant international legal network with strong ties amongst its highly professional members that go beyond any ordinary network.
 
An EMEA Meeting wouldn't be a LAWorld Meeting if we didn't also have fun and enjoy great times with our LAWorld friends. Thank’s again to our friends from the hosting law firm The Law Firm / Moutzouridou - Sakellariou & Associates for organizing a wonderful conference. It was a great pleasure for us.

The pictures of the after movie speak for themselves, enjoy watching it!

BGPartner is pleased to welcome Barbara Meise (Attorney-at-law at the Berne office) und Manuela Ortelli (Trainee at the Zurich

office) as of March 1, 2023. Further information on our entire team can be found here.

Six months to go until the revised Data Protection Act comes into force on September 1, 2023. Do you have an up-to-date data protection declaration? Do you know how to respond to a request for information? Have you outsourced services to third-party companies that process personal data on your behalf? Have you defined a process for reporting data security breaches (such as loss, deletion, or modification of personal data due to hacker attacks, etc.)?

Prepare yourself for the new requirements. Our data protection expert, attorney-at-law Fabiola Weilenmann, together with the entire BGPartner team, will be happy to advise and support you in implementing the new requirements.

Another VisMootCourt Trial Round in the books! This time we had the privilege of hosting the teams of Universität Bern and Université de Genève who did an outstanding job with their pleadings.

BGPartner continues to be impressed with the determination and investment these students are willing to put in. It clearly pays off, as their performances were excellent. You have done a fantastic job. 
 
Find out in the After Movie what the students benefited most from, how realistic a trial round is, what the preparation looks like and why BGPartner continues to support this project. Enjoy watching.